ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

10 Fibro-Friendly Foods with a Bonus: Beautiful Skin

Fight Back! Win the War Being Waged Against Your Immune System

Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant...

Clary Sage Oil May Be Pricey, but Its Benefits Are Priceless

Component of red wine, grapes can help to reduce inflammation, study finds

Poly MVA: A Novel Therapy for Increasing Energy, Repairing DNA, and Promoting Overall Health

Pumpkin Pie Turmeric Breakfast Smoothie - Vegan + Gluten-Free

Vitamin D supplementation extends life in mouse model of Huntington's disease

What’s Fenugreek Good For?

Omega-3 fatty acid stops known trigger of lupus

Print Page
Email Article

New Study Results Show Benefit for Alzheimer's Disease Patients Taking Lipitor(TM)

  [ 286 votes ]   [ Discuss This Article ] • April 15, 2004

SUN CITY, Ariz., April 14 /PRNewswire/ --

Results of a Sun City, Arizona research study unveiled today in Montreal showed that Lipitor(TM), a cholesterol-lowering medication, slows the progression and reduces the deterioration of Alzheimer's Disease (AD). D. Larry Sparks, Ph.D., a senior scientist at the Sun Health Research Institute, announced at a news conference today coinciding with the start of the 8th International Montreal/Springfield Symposium on Advances in Alzheimer's Therapy with more than 300 scientists from 15 countries worldwide in attendance.

Dr. Sparks is principal investigator for the 63-participant AD Cholesterol-Lowering Treatment Trial. A total of two-thirds of patients on active medication derived some clinical benefit. Half of the patients stabilized or actually improved. Participants in Dr. Sparks' one-year treatment trial received either Lipitor(TM) or a placebo. Conducted as a double-blind study, mild to moderately affected patients were allowed to continue use of the FDA-approved Alzheimer's medications (acetylcholine esterase inhibitors).

"This is truly exciting news," Dr. Sparks exclaims. "Results indicate not only a slowing in deterioration of function and memory but also an improvement in mood and behavior. No prior clinical trials have actually shown long-term improvement in patients with AD." Dr. Sparks' pioneering research has been consistently confirmed in other studies clearly suggesting that cholesterol may exacerbate the progression of AD.

"While trial results are preliminary, they provide important information for patients who suffer from AD. Future research is needed to answer important questions, such as: 'Will cholesterol-lowering medications prevent AD from occurring altogether if taken before the earliest onset of the disease?' and 'What about the benefits of statin therapy in combination with AD medications on the horizon?'" he says.

Although Dr. Sparks' findings show great promise, individuals are encouraged to seek the advice of their physicians regarding the suitability of using cholesterol-lowering medication. In Dr. Sparks' study, participants were not excluded from medications they already were taking for pre-existing conditions. Results indicate Lipitor(TM) was effective regardless of other medications already being taken, a reflection on the drug's effectiveness on a broad scale in real-life scenarios.

In addition to this trial, Dr. Sparks also is participating in the ongoing LEADe study sponsored by Pfizer, Inc., which is comparing the efficacy and safety of Lipitor(TM) in combination with donepezil (Aricept(TM)) in a large group of patients with mild to moderate AD. Dr. Sparks' AD Cholesterol-lowering Treatment Trial was the first clinical trial of its kind designed to test the clinical benefits of atorvastatin (Lipitor(TM)) in both memory and behavioral measures.

The study received initial support from the Institute for the Study on Aging (ISOA), which awarded Dr. Sparks a $450,000 grant. Additional support and funding came from Pfizer Pharmaceutical, Inc., which also supplied Lipitor(TM) and placebo for the study. The ISOA, a New-York based private foundation established by the Estee Lauder Trust whose mission is drug discovery for AD, gave its full support to Dr. Sparks upon realizing the potential of this study for individuals with AD.

"The ISOA was the funding catalyst for this pioneering study," explains Dr. Sparks. "They, together with Pfizer, supported the study because they believed in the research rationale and really took a chance that I was on the right track." "Today, everyone is a winner with this news because it brings us one step closer to another effective treatment for this mind-robbing disease."

Dr. Sparks' work has generated a significant amount of local and national interest. His pioneering studies linking high blood pressure, coronary artery disease and elevated cholesterol levels to AD have been highlighted by many well-respected news outlets. These include Newsweek (two separate stories), CNN, ABC World News Tonight, NBC Nightly News with Tom Brokaw, Reuters and Bloomberg news services, ABC Radio and research publications such as Science and Neurology.

The principal investigator also has led studies showing that many of the changes in the brain characteristic of AD can be found in patients with critical coronary-artery disease or hypertension. Research indicates the onset of these diseases can occur approximately 10 to 15 years prior to the onset of the first signs of AD. In less than a generation of painstaking investigation, scientists at the internationally recognized Sun Health Research Institute in Sun City, Arizona, northwest of Phoenix, have developed breakthroughs for some of the most debilitating age-related diseases affecting seniors.

Source: Sun Health Research Institute

Post a Comment

Featured Products From the ProHealth Store
Energy NADH™ 12.5mg Ultra ATP+, Double Strength Ultra EPA  - Fish Oil

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Natural Pain Relief Supplements

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Vitamin K-2 – A Key Player in Cardiovascular and Bone Health Vitamin K-2 – A Key Player in Cardiovascular and Bone Health
D-ficient? Health Risks You Need to Know About D-ficient? Health Risks You Need to Know About
Why Berries Offer a Rainbow of Health Benefits Why Berries Offer a Rainbow of Health Benefits
Soothe, Heal and Regulate Your Digestive System with Nutrient-Rich Aloe Vera Soothe, Heal and Regulate Your Digestive System with Nutrient-Rich Aloe Vera
Safely Burn Away Body Fat Safely Burn Away Body Fat

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map